rs142014203
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_001304533.3(NKAIN3):c.54+97231T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0213 in 152,126 control chromosomes in the GnomAD database, including 64 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.021 ( 64 hom., cov: 32)
Consequence
NKAIN3
NM_001304533.3 intron
NM_001304533.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.552
Publications
3 publications found
Genes affected
NKAIN3 (HGNC:26829): (sodium/potassium transporting ATPase interacting 3) NKAIN3 is a member of a family of mammalian proteins (see NKAIN1; MIM 612871) with similarity to Drosophila Nkain (Gorokhova et al., 2007 [PubMed 17606467]).[supplied by OMIM, Jun 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0213 (3245/152126) while in subpopulation NFE AF = 0.0335 (2279/67966). AF 95% confidence interval is 0.0324. There are 64 homozygotes in GnomAd4. There are 1485 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 64 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NKAIN3 | NM_001304533.3 | c.54+97231T>G | intron_variant | Intron 1 of 6 | ENST00000623646.3 | NP_001291462.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NKAIN3 | ENST00000623646.3 | c.54+97231T>G | intron_variant | Intron 1 of 6 | 6 | NM_001304533.3 | ENSP00000501908.1 |
Frequencies
GnomAD3 genomes AF: 0.0213 AC: 3245AN: 152008Hom.: 63 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
3245
AN:
152008
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0213 AC: 3245AN: 152126Hom.: 64 Cov.: 32 AF XY: 0.0200 AC XY: 1485AN XY: 74368 show subpopulations
GnomAD4 genome
AF:
AC:
3245
AN:
152126
Hom.:
Cov.:
32
AF XY:
AC XY:
1485
AN XY:
74368
show subpopulations
African (AFR)
AF:
AC:
235
AN:
41532
American (AMR)
AF:
AC:
482
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
AC:
58
AN:
3472
East Asian (EAS)
AF:
AC:
1
AN:
5166
South Asian (SAS)
AF:
AC:
31
AN:
4822
European-Finnish (FIN)
AF:
AC:
27
AN:
10612
Middle Eastern (MID)
AF:
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2279
AN:
67966
Other (OTH)
AF:
AC:
75
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
160
320
480
640
800
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.